EIKN Eikon Therapeutics, Inc.: institutional ownership and insider trading
82 funds reported holding $344M of Eikon Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $35.9M, with 37 new positions and 12 funds selling out; over the last 12 months insiders bought $52.2M and sold $0 on the open market.
EIKN revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$88.4M, EPS -1.63
- Quarter ended Mar 31, 2026: revenue n/a, net income −$83.0M, EPS -2.46
- Quarter ended Jun 30, 2025: revenue n/a, net income −$105M, EPS -36.94
- Quarter ended Mar 31, 2025: revenue n/a, net income −$68.2M, EPS -26.91
Famous investors holding EIKN
- Izzy Englander (Millennium Management): $1.74M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $350K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $170K, 0.0% of the portfolio
Largest institutional holders of EIKN
- FMR LLC — $65.2M
- BlackRock, Inc. (BLK) — $55.9M
- Foresite Capital Management IV, LLC — $25.4M
- Merck & Co., Inc. (MRK) — $21.7M
- T. Rowe Price Investment Management, Inc. — $20.8M
- Foresite Capital Management V, LLC — $17.2M
- Capital World Investors — $15.3M
- PRICE T ROWE ASSOCIATES INC /MD/ — $13.1M
- VANGUARD CAPITAL MANAGEMENT LLC — $12.0M
- EcoR1 Capital, LLC — $9.56M
Recent EIKN insider trades
- Sep 3, 2026: Svennilson Peter bought 89,200 shares ($1.03M)
- Feb 6, 2026: Svennilson Peter bought 2,117,760 shares ($38.1M)
- Feb 4, 2026: Frazier Kenneth C bought 111,111 shares ($2.00M)
- Feb 4, 2026: Wolfe Josh bought 277,776 shares ($5.00M)
5%+ owners
- FMR LLC: 10.2% (Schedule 13G/A, filed Oct 7, 2026)
- BlackRock Portfolio Management LLC: 5.5% (Schedule 13G, filed Apr 29, 2026)
- PERLMUTTER ROGER M: 5.2% (Schedule 13G, filed May 13, 2026)
- Innovation Endeavors III LP: 5.0% (Schedule 13G, filed May 15, 2026)
Who owns the most EIKN stock?
The largest institutional holders of Eikon Therapeutics, Inc. in the latest 13F filings are FMR LLC ($65.2M), BlackRock, Inc. (BLK) ($55.9M), Foresite Capital Management IV, LLC ($25.4M).
Are insiders buying or selling EIKN?
Over the last 12 months insiders bought $52.2M and sold $0 of Eikon Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own EIKN?
Izzy Englander, Renaissance Technologies, Ken Griffin.
Which ETFs hold EIKN?
4 ETFs and mutual funds hold it among their top 100 positions, including FBIOX, SHISX, TINY, TMED.